查詢結果分析
相關文獻
- 標靶藥物和免疫治療在視網膜疾病治療之角色
- Tomographic Changes in Diabetic Macular Edema Managed by Intravitreal Bevacizumab with or without Posterior Subtenon Injection of Triamcinolone
- Short-Term Response of Diabetic Macular Edema to Intravitreal Bevacizumab: An Optical Coherence Tomographic Patterns Analysis
- Foveal Contour in Advanced ROP Following Intravitreal Bevacizumab or Laser
- 標靶藥物、免疫治療、生物製劑的前眼部副作用
- Central Retinal Vein Occlusion Associated with Cryofibrinogenemia in a Young Adult--Study of Skin Dynamic Capillaroscopy
- 老年性黃斑部病變之境界不明脈絡膜新生血管的灌流變化
- 早產兒視網膜病變之手術治療
- 早產兒視網膜病變眼科與新生兒科醫師之聯合照顧
- 早產兒視網膜病變之病理變化機轉
頁籤選單縮合
題 名 | 標靶藥物和免疫治療在視網膜疾病治療之角色=The Role of Target Therapy and Immunotherapy in the Treatment of Retinal Diseases |
---|---|
作 者 | 蘇致騏; 賴佐庭; | 書刊名 | 臺灣醫學 |
卷 期 | 25:4 2021.07[民110.07] |
頁 次 | 頁503-511 |
專 輯 | 眼科疾病的標靶治療 |
分類號 | 416.746 |
關鍵詞 | 標靶藥物; 免疫治療; 血管新生因子; 老年性黃斑部病變; 糖尿病黃斑部水腫; 視網膜靜脈阻塞; 早產兒視網膜病變; 玻璃體內注射; Target therapy; Immunotherapy; VEGF; Age-related macular degeneration; Diabetic macular edema; Retinal vein occlusion; Retinopathy of prematurity; Intravitreal injection; |
語 文 | 中文(Chinese) |